T3 Pharmaceuticals wins W.A. de Vigier Award T3 Pharmaceuticals is among the winners of this year’s W.A. de Vigier Award. The spin-off…Jérémie Meyer05.28.2019
BaseLaunch is top European accelerator Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization BaselArea.swiss, is among the…Jérémie Meyer05.21.2019
Tackling the healthcare innovation chasm | News 13.05.2019The diagnosis couldn’t be worse. Healthcare innovation as we know it is stagnating…Jérémie Meyer05.13.2019
Pfizer acquires Basel-based Therachon U.S. pharmaceutical company Pfizer is acquiring Basel biotech Therachon for US$ 340 million. Additional payments…Jérémie Meyer05.09.2019
Switzerland excels with biotech start-ups According to an article in the journal “Nature”, Switzerland is the European leader with its…Jérémie Meyer05.06.2019
Alentis raises 12.5 million Swiss francs The Basel-based biotech company Alentis Therapeutics AG has successfully concluded a CHF 12.5 million Series…Jérémie Meyer04.30.2019
Fully equipped lab spaces at the Switzerland Innovation Park Basel Area Launching a biotech is a daunting endeavor. Resources – both human and capital - are…Jérémie Meyer04.29.2019
Basel’s Lyfegen closes seed financing round Lyfegen, an IT company specializing in healthcare from Basel, has raised 750,000 Swiss francs in…Jérémie Meyer04.18.2019
Novartis subsidiary Alcon is now an independent company Novartis completed the spin-off of the Alcon eye care devices business through a dividend-in-kind distribution.…Jérémie Meyer04.09.2019
Innolith makes breakthrough in vehicle batteries Energy company Innolith has developed a new type of battery that gives electric vehicles a…Jérémie Meyer04.04.2019